Report Detail

Request for Sample of this report

Pharma & Healthcare Global and United States Chronic Urticaria Or Hives Drug Market Insights, Forecast to 2026

  • RnM4198633
    • |
  • 10 September, 2020
    • |
  • Global
    • |
  • 141 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Chronic Urticaria Or Hives Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Urticaria Or Hives Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Chronic Urticaria Or Hives Drug market is segmented into
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others

Segment by Application, the Chronic Urticaria Or Hives Drug market is segmented into
Clinic
Hospital
Others

Regional and Country-level Analysis
The Chronic Urticaria Or Hives Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Urticaria Or Hives Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Chronic Urticaria Or Hives Drug Market Share Analysis
Chronic Urticaria Or Hives Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Urticaria Or Hives Drug business, the date to enter into the Chronic Urticaria Or Hives Drug market, Chronic Urticaria Or Hives Drug product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited


1 Study Coverage

  • 1.1 Chronic Urticaria Or Hives Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Chronic Urticaria Or Hives Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Type
    • 1.4.2 GDC-0853
    • 1.4.3 GSK-2646264
    • 1.4.4 BF-Derm-1
    • 1.4.5 Bilastine
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Application
    • 1.5.2 Clinic
    • 1.5.3 Hospital
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Chronic Urticaria Or Hives Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Chronic Urticaria Or Hives Drug Revenue 2015-2026
    • 2.1.2 Global Chronic Urticaria Or Hives Drug Sales 2015-2026
  • 2.2 Global Chronic Urticaria Or Hives Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Chronic Urticaria Or Hives Drug Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Chronic Urticaria Or Hives Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Chronic Urticaria Or Hives Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Chronic Urticaria Or Hives Drug Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2021-2026)

3 Global Chronic Urticaria Or Hives Drug Competitor Landscape by Players

  • 3.1 Global Top Chronic Urticaria Or Hives Drug Sales by Manufacturers
    • 3.1.1 Global Chronic Urticaria Or Hives Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Chronic Urticaria Or Hives Drug Manufacturers by Revenue
    • 3.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Chronic Urticaria Or Hives Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Chronic Urticaria Or Hives Drug Revenue in 2019
    • 3.2.5 Global Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Chronic Urticaria Or Hives Drug Price by Manufacturers
  • 3.4 Global Chronic Urticaria Or Hives Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Chronic Urticaria Or Hives Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Chronic Urticaria Or Hives Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Chronic Urticaria Or Hives Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Chronic Urticaria Or Hives Drug Sales by Type (2015-2020)
    • 4.1.2 Global Chronic Urticaria Or Hives Drug Revenue by Type (2015-2020)
    • 4.1.3 Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Chronic Urticaria Or Hives Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Chronic Urticaria Or Hives Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Chronic Urticaria Or Hives Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Chronic Urticaria Or Hives Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Chronic Urticaria Or Hives Drug Sales by Application (2015-2020)
    • 5.1.2 Global Chronic Urticaria Or Hives Drug Revenue by Application (2015-2020)
    • 5.1.3 Chronic Urticaria Or Hives Drug Price by Application (2015-2020)
  • 5.2 Chronic Urticaria Or Hives Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Chronic Urticaria Or Hives Drug Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Chronic Urticaria Or Hives Drug Market Size YoY Growth 2015-2026
    • 6.1.1 United States Chronic Urticaria Or Hives Drug Sales YoY Growth 2015-2026
    • 6.1.2 United States Chronic Urticaria Or Hives Drug Revenue YoY Growth 2015-2026
    • 6.1.3 United States Chronic Urticaria Or Hives Drug Market Share in Global Market 2015-2026
  • 6.2 United States Chronic Urticaria Or Hives Drug Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Chronic Urticaria Or Hives Drug Players by Sales (2015-2020)
    • 6.2.2 United States Top Chronic Urticaria Or Hives Drug Players by Revenue (2015-2020)
  • 6.3 United States Chronic Urticaria Or Hives Drug Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Chronic Urticaria Or Hives Drug Price by Type (2015-2020)
  • 6.4 United States Chronic Urticaria Or Hives Drug Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Chronic Urticaria Or Hives Drug Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Chronic Urticaria Or Hives Drug Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Chronic Urticaria Or Hives Drug Price Forecast by Type (2021-2026)
  • 6.5 United States Chronic Urticaria Or Hives Drug Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Chronic Urticaria Or Hives Drug Price by Application (2015-2020)
  • 6.6 United States Chronic Urticaria Or Hives Drug Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Chronic Urticaria Or Hives Drug Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Chronic Urticaria Or Hives Drug Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Chronic Urticaria Or Hives Drug Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Chronic Urticaria Or Hives Drug Market Size YoY Growth 2015-2026
  • 7.2 North America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
    • 7.2.1 North America Chronic Urticaria Or Hives Drug Sales by Country (2015-2020)
    • 7.2.2 North America Chronic Urticaria Or Hives Drug Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Chronic Urticaria Or Hives Drug Market Size YoY Growth 2015-2026
  • 8.2 Europe Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
    • 8.2.1 Europe Chronic Urticaria Or Hives Drug Sales by Country
    • 8.2.2 Europe Chronic Urticaria Or Hives Drug Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Chronic Urticaria Or Hives Drug Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Chronic Urticaria Or Hives Drug Market Size YoY Growth 2015-2026
  • 10.2 Latin America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
    • 10.2.1 Latin America Chronic Urticaria Or Hives Drug Sales by Country
    • 10.2.2 Latin America Chronic Urticaria Or Hives Drug Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country
    • 11.2.2 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 AstraZeneca Plc
    • 12.1.1 AstraZeneca Plc Corporation Information
    • 12.1.2 AstraZeneca Plc Description and Business Overview
    • 12.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products Offered
    • 12.1.5 AstraZeneca Plc Recent Development
  • 12.2 Biofrontera AG
    • 12.2.1 Biofrontera AG Corporation Information
    • 12.2.2 Biofrontera AG Description and Business Overview
    • 12.2.3 Biofrontera AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Products Offered
    • 12.2.5 Biofrontera AG Recent Development
  • 12.3 ELORAC, Inc.
    • 12.3.1 ELORAC, Inc. Corporation Information
    • 12.3.2 ELORAC, Inc. Description and Business Overview
    • 12.3.3 ELORAC, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Products Offered
    • 12.3.5 ELORAC, Inc. Recent Development
  • 12.4 Faes Farma, SA
    • 12.4.1 Faes Farma, SA Corporation Information
    • 12.4.2 Faes Farma, SA Description and Business Overview
    • 12.4.3 Faes Farma, SA Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Products Offered
    • 12.4.5 Faes Farma, SA Recent Development
  • 12.5 Genentech, Inc.
    • 12.5.1 Genentech, Inc. Corporation Information
    • 12.5.2 Genentech, Inc. Description and Business Overview
    • 12.5.3 Genentech, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Products Offered
    • 12.5.5 Genentech, Inc. Recent Development
  • 12.6 GlaxoSmithKline Plc
    • 12.6.1 GlaxoSmithKline Plc Corporation Information
    • 12.6.2 GlaxoSmithKline Plc Description and Business Overview
    • 12.6.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Products Offered
    • 12.6.5 GlaxoSmithKline Plc Recent Development
  • 12.7 J Uriach Y Compania, S.A.
    • 12.7.1 J Uriach Y Compania, S.A. Corporation Information
    • 12.7.2 J Uriach Y Compania, S.A. Description and Business Overview
    • 12.7.3 J Uriach Y Compania, S.A. Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Products Offered
    • 12.7.5 J Uriach Y Compania, S.A. Recent Development
  • 12.8 Mabtech Limited
    • 12.8.1 Mabtech Limited Corporation Information
    • 12.8.2 Mabtech Limited Description and Business Overview
    • 12.8.3 Mabtech Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Products Offered
    • 12.8.5 Mabtech Limited Recent Development
  • 12.9 Merck & Co., Inc.
    • 12.9.1 Merck & Co., Inc. Corporation Information
    • 12.9.2 Merck & Co., Inc. Description and Business Overview
    • 12.9.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Products Offered
    • 12.9.5 Merck & Co., Inc. Recent Development
  • 12.10 Mycenax Biotech Inc.
    • 12.10.1 Mycenax Biotech Inc. Corporation Information
    • 12.10.2 Mycenax Biotech Inc. Description and Business Overview
    • 12.10.3 Mycenax Biotech Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Products Offered
    • 12.10.5 Mycenax Biotech Inc. Recent Development
  • 12.11 AstraZeneca Plc
    • 12.11.1 AstraZeneca Plc Corporation Information
    • 12.11.2 AstraZeneca Plc Description and Business Overview
    • 12.11.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products Offered
    • 12.11.5 AstraZeneca Plc Recent Development
  • 12.12 Panacea Biotec Limited
    • 12.12.1 Panacea Biotec Limited Corporation Information
    • 12.12.2 Panacea Biotec Limited Description and Business Overview
    • 12.12.3 Panacea Biotec Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 Panacea Biotec Limited Products Offered
    • 12.12.5 Panacea Biotec Limited Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Chronic Urticaria Or Hives Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Chronic Urticaria Or Hives Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Chronic Urticaria Or Hives Drug. Industry analysis & Market Report on Chronic Urticaria Or Hives Drug is a syndicated market report, published as Global and United States Chronic Urticaria Or Hives Drug Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Chronic Urticaria Or Hives Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,108.30
    		4,662.45
    		6,216.60
    		3,623.10
    		5,434.65
    		7,246.20
    		596,427.00
    		894,640.50
    		1,192,854.00
    		325,338.00
    		488,007.00
    		650,676.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo